Point72 Europe »

Biogen Idec shares owned by Point72 Europe

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Point72 Europe

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 99k 140.08
2025-06-30 $12M 96k 125.59
2025-03-31 $11M 83k 136.84

More positions owned by Point72 Europe

Strategy Cl A New (MSTR)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Capital One Financial (COF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Key (KEY)
Charles Schwab Corporation (SCHW)
TPG Com Cl A (TPG)
WESCO International (WCC)
Bank of America Corporation (BAC)
Regeneron Pharmaceuticals (REGN)
Suncor Energy (SU)
Linde SHS (LIN)

View all positions for Point72 Europe

Top funds holding Biogen Idec

Vanguard Group
BlackRock
PRIMECAP Management Company
State Street Corporation
Wellington Management Company
Geode Capital Management
Point72 Asset Management
Norges Bank Investment Management
Susquehanna International
AQR Capital Management
Robeco Investment Management
Invesco
Barclays
Legal & General Group
Millennium Management

View all funds holding Biogen Idec